United Kingdom· GB-APID-4262311000001103
IntronA 18million units/1.2ml solution for injection multidose pens
A interferon alfa-2b product containing interferon alfa-2b, registered in United Kingdom by Organon Pharma (UK) Ltd. The same ATC class is registered in 5 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Interferon alfa-2b is registered in 5 of 19 countries.
Countries holding a registration under ATC L03AB05 (interferon alfa-2b), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 3 of them publish a price we can compare per daily dose
Interferon alfa-2b · ATC L03AB05
5 / 19 countries
- Belgiumprice
- Finlandprice
- Netherlands
- Spainprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Interferon alfa-2b
- Manufacturer
- Organon Pharma (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- L03AB05
- ATC class
- Interferon alfa-2b
- Defined daily dose
- 2 MIO, E
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5012376023755
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
230 interactions on record for interferon alfa-2b.
Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Interferon alfa-2b · interactions on record
230 records
- 37 severe
- 191 moderate
- 2 minor
Most severe, free to view
- EltrombopagB02BX05severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- ZidovudineJ05AF01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Interferon alfa-2b in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandIntronaSchering-Plough Europe
- BelgiumIntronA 10000000 IU/mlMerck Sharp & Dohme
- NetherlandsIntronA 18 miljoen IE, oplossing voor injectie in een multidosis penMerck Sharp & Dohme B.V.
- SpainINTRONA 10 MILLONES DE UI/ml SOLUCION INYECTABLE O PARA PERFUSIONMerck Sharp & Dohme B.V.
- IrelandViraferonSchering Plough Europe
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e3b53911-3bdc-44d9-8e50-fabf70f773d8 GET /v1/drugs/e3b53911-3bdc-44d9-8e50-fabf70f773d8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4262311000001103",
"desc": "IntronA 18million units/1.2ml solution for injection multidose pens (Organon Pharma (UK) Ltd)",
"form": "Solution for injection",
"vpid": "4263111000001106",
"source": "dmd",
"vtm_id": "776348001",
"strength": "15 mega unit",
"substance": "Interferon alfa-2b",
"ingredient": "Interferon alfa-2b",
"supplier_code": "3146901000001106"
}See everything about interferon alfa-2b.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.